We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$202M
AUM Growth
+$11.2M
Cap. Flow
+$176K
Cap. Flow %
0.09%
Top 10 Hldgs %
63.71%
Holding
385
New
9
Increased
31
Reduced
46
Closed
27

Sector Composition

Rank Sector Weight
1 Real Estate 1.83%
2 Healthcare 0.58%
3 Technology 0.54%
4 Financials 0.48%
5 Consumer Staples 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCN
226
Waste Connections
WCN
$42.3B
$8K ﹤0.01%
144
SPLK
227
DELISTED
Splunk Inc
SPLK
$8K ﹤0.01%
127
CHK
228
DELISTED
Chesapeake Energy Corporation
CHK
$8K ﹤0.01%
7
CELG
229
DELISTED
Celgene Corp
CELG
$8K ﹤0.01%
67
ENV
230
DELISTED
ENVESTNET, INC.
ENV
$8K ﹤0.01%
262
BXP icon
231
Boston Properties
BXP
$11.2B
$7K ﹤0.01%
52
ECL icon
232
Ecolab
ECL
$78.6B
$7K ﹤0.01%
54
ELS icon
233
Equity Lifestyle Properties
ELS
$12.7B
$7K ﹤0.01%
174
EWC icon
234
iShares MSCI Canada ETF
EWC
$6.16B
$7K ﹤0.01%
274
HPQ icon
235
HP
HPQ
$24.8B
$7K ﹤0.01%
400
NVO
236
Novo Nordisk
NVO
$208B
$7K ﹤0.01%
422
PEG icon
237
Public Service Enterprise Group
PEG
$38.2B
$7K ﹤0.01%
150
PVH icon
238
PVH
PVH
$4.09B
$7K ﹤0.01%
63
SBUX icon
239
Starbucks
SBUX
$118B
$7K ﹤0.01%
124
-200
-62% -$11.3K
SKX
240
DELISTED
Skechers
SKX
$7K ﹤0.01%
245
NBIS
241
Nebius Group N.V.
NBIS
$54B
$7K ﹤0.01%
306
PFPT
242
DELISTED
Proofpoint, Inc.
PFPT
$7K ﹤0.01%
99
ALXN
243
DELISTED
Alexion Pharmaceuticals
ALXN
$7K ﹤0.01%
61
TWX
244
DELISTED
Time Warner Inc
TWX
$7K ﹤0.01%
76
AR icon
245
Antero Resources
AR
$11.2B
$6K ﹤0.01%
283
DOX icon
246
Amdocs
DOX
$5.88B
$6K ﹤0.01%
92
EWJ icon
247
iShares MSCI Japan ETF
EWJ
$22B
$6K ﹤0.01%
124
ICLR icon
248
Icon
ICLR
$12.2B
$6K ﹤0.01%
71
OPLN
249
Openlane
OPLN
$4.36B
$6K ﹤0.01%
380
LOPE icon
250
Grand Canyon Education
LOPE
$3.93B
$6K ﹤0.01%
80

Similar funds

Roble Belko & Company's Q1 2017 Portfolio in Review

As of Q1 2017, Roble Belko & Company held 385 positions worth $202M, up 5.9% from $191M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Roble Belko & Company's Q1 2017 filing shows 9 new, 31 increased, 46 reduced and 27 closed positions. Its largest new stake was iShares iBonds Dec 2020 Term Corporate ETF: 9,884 shares worth $251K. The largest sale was Vanguard Real Estate ETF, an estimated $1.97M.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Technology.

  • Roble Belko & Company's largest Q1 2017 buy was iShares iBonds Dec 2020 Term Corporate ETF: 9,884 shares worth $251K.
  • Roble Belko & Company added most to Vanguard Total International Stock ETF in Q1 2017, an estimated $2.09M increase.
  • Roble Belko & Company's biggest Q1 2017 reduction was Vanguard Real Estate ETF, cutting an estimated $1.97M.
  • Roble Belko & Company fully exited Apollo Commercial Real Estate in Q1 2017, selling an estimated $1.93M.
  • Roble Belko & Company's ten largest holdings make up 64% of its $202M portfolio in Q1 2017.
  • Roble Belko & Company opened 9 new positions and closed 27 in Q1 2017.
  • Roble Belko & Company's portfolio value rose 5.9% quarter-over-quarter to $202M.

Based on Roble Belko & Company's 13F filing for Q1 2017, filed 12 May 2017.